Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$823.10B | 41.8x | 1.96 | US$102.46 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Kroger | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$47.34B | 17.2x | 0.34 | US$65.42 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
Sysco | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$34.94B | 18.2x | -4 | US$71.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Koninklijke Ahold ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$33.47B | 17.8x | -1.16 | US$36.32 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Koninklijke Ahold NV | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$33.47B | 17.8x | -1.15 | US$34.87 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$32.43B | 20.6x | -2.9 | US$14.65 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.6% Upside | Upgrade to Pro+ | |
Tesco PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$32.43B | 20.6x | -2.9 | US$4.56 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fomento Economico Mexicano | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$28.43B | 27.3x | -0.29 | US$85.10 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Sprouts Farmers | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.94B | 48.3x | 1.05 | US$169.43 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -18% Downside | Upgrade to Pro+ | |
US Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.78B | 30.7x | 0.99 | US$72.02 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Coles Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$16.09B | 23x | 12.89 | US$11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Caseys | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$15.94B | 29.6x | 2.65 | US$429.42 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.7% Upside | Upgrade to Pro+ | |
CP All ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.81B | 20.2x | 0.42 | US$17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Performance Food Group Co | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$13.75B | 36.5x | 45.83 | US$88.22 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.4% Upside | Upgrade to Pro+ | |
Jeronimo Martins SGPS SA ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$12.77B | 19x | -1.5 | US$40.75 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.8% Upside | Upgrade to Pro+ | |
Albertsons | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$11.82B | 11.4x | -0.46 | US$20.40 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Dino Polska ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$11.07B | 31.1x | 9.58 | US$58 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carrefour SA PK | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.49B | 11.6x | -0.19 | US$2.84 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.7% Upside | Upgrade to Pro+ | |
Luckin Coffee | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.42B | 26.5x | -3.24 | US$29.50 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14% Upside | Upgrade to Pro+ | |
Marks and Spencer | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.03B | 14x | 0.57 | US$3.89 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marks & Spencer Group Plc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$9.03B | 14x | 0.57 | US$9.02 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.2% Upside | Upgrade to Pro+ | |
Walgreens Boots | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.75B | -1x | 0 | US$10.12 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
Shoprite ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$8.24B | 24.7x | 3.88 | US$15.18 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
J Sainsbury PLC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$7.61B | 104.9x | -1.27 | US$13.24 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.6% Downside | Upgrade to Pro+ | |
Kesko ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$7.22B | 19.4x | -0.88 | US$9.07 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Raia Drogasil ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$5.83B | 29.6x | 7.71 | US$3.60 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Axfood ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.62B | 24x | -3.09 | US$25.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Etablissementen Franz Colruyt ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.59B | 12.6x | -0.19 | US$9.46 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clicks Group | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$4.46B | 29.5x | 2.12 | US$38.29 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BBB Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$3.21B | 250.3x | 2.06 | US$28.57 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.5% Upside | Upgrade to Pro+ | |
DFI Retail Holdings DRC | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$3.21B | 26.4x | 0.08 | US$11.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Chefs Warehouse | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.23B | 44x | 0.37 | US$55.12 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Sun Art Retail ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$2.17B | -15.3x | 0.03 | US$2.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Weis Markets | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.88B | 19.5x | -1.3 | US$69.98 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
United Natural Foods | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.85B | -19.4x | 1.23 | US$30.93 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Hellofresh | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.75B | -14.9x | 0.04 | US$10.15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Thumb Industries | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.69B | 26x | 0.06 | US$7.18 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grocery Outlet | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.67B | 32.9x | -0.83 | US$17.20 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.3% Downside | Upgrade to Pro+ | |
Vital Farms | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.65B | 31.9x | 0.25 | US$37.69 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.9% Upside | Upgrade to Pro+ | |
Sendas Distribuidora | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.59B | 74x | -0.64 | US$5.95 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
Guardian Pharmacy Services | NYSE | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.46B | -13.8x | US$23.11 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | ||
SPAR ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.44B | 76.8x | -1.3 | US$6.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ingles | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.28B | 12x | -0.24 | US$67.47 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pick N Pay ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$1.13B | -4.5x | 0 | US$6.84 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Robinsons Retail Holdings Inc | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$833.65M | 5.3x | 0.04 | US$5.89 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SpartanNash Co | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$633.58M | 13.8x | 1.36 | US$18.77 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.4% Upside | Upgrade to Pro+ | |
Village Super Market | NASDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | US$514.26M | 10x | 4.09 | US$34.84 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Verano Holdings | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$425.32M | -4.3x | -0.07 | US$1.20 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven & i Co | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$407.91M | 58.9x | -1.14 | US$16.50 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seven i ADR | OTC Markets | Consumer Non-Cyclicals | Food & Drug Retailing | US$407.91M | 58.9x | -1.14 | US$15.85 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |